Narrow DCIS Margins May Not Always Warrant Reexcision - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Narrow DCIS Margins May Not Always Warrant Reexcision

An ancillary analysis found less than 2-percentage-point differences in 10-year recurrence across margin thresholds, with no statistically significant adjusted association.

  • By

  • Andrea Surnit

  • July 20, 2026

  • 6 min

Share

Clinical Scorecard: Narrow DCIS Margins May Not Always Warrant Reexcision

At a Glance

CategoryDetail
ConditionDuctal Carcinoma In Situ (DCIS)
Key MechanismsAssociation of margin width with ipsilateral breast tumor recurrence (IBTR) rates.
Target PopulationPostmenopausal patients with hormone receptor-positive DCIS.
Care SettingBreast-conserving surgery and whole-breast irradiation.

Key Highlights

  • Narrower negative margins correlated with slightly higher 10-year IBTR rates.
  • Margin width not statistically significant for recurrence after adjustment for confounding factors.
  • Current guidelines recommend a 2-mm negative margin for DCIS.
  • Omission of reexcision for narrow margins may be reconsidered in selected patients.
  • Tumor size remains a significant factor for recurrence risk.

Guideline-Based Recommendations

Diagnosis

  • Assess margin width in patients undergoing breast-conserving surgery.

Management

  • Consider personalized decision-making regarding reexcision based on margin width.

Monitoring & Follow-up

  • Monitor for ipsilateral breast tumor recurrence in patients with narrow margins.

Risks

  • Higher recurrence risk associated with larger tumor size.

Patient & Prescribing Data

Postmenopausal patients with hormone receptor-positive DCIS.

65% completed 5 years of endocrine therapy, adherence did not differ by margin group.

Clinical Best Practices

  • Follow current consensus guidelines for margin width in DCIS.
  • Evaluate genomic profiles for recurrence risk assessment.

Related Resources & Content

Original Source(s)

Narrow DCIS Margins May Not Always Warrant Reexcision

  • by Andrea Surnit

  • July 20, 2026

Related Content

High-Dose Vitamin C Could Pose Risk in Severe Burns

“High-dose intravenous vitamin C administered early after injury did not reduce organ dysfunction or [mortality] and should not be a treatment in severe burns.”

Medical Oddities: When a Brush Beats a Scalpel

This research roundup has brain drama, bleeding control, skin science, and tiny brushes.

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.